Marketing-authorisation holder · Germany
Dr. Falk Pharma Gmbh
56 medicines in 6 countries, as authorisation holder and manufacturer.
Loading your page…
Loading your page…
Marketing-authorisation holder · Germany
56 medicines in 6 countries, as authorisation holder and manufacturer.
One free account for the Prognia apps: Ward to study, Osler for clinical answers with their sources, and the network to find your colleagues.
Groups are put together by Prognia from the names regulators publish and from company links; they are not an official corporate structure.
Every medicine in the registers under its name, current ones first.
1–25 of 56
| Medicine | Substance | Country | Status | Authorised |
|---|---|---|---|---|
| Budenofalk 4 mg zetpillenZetpil | Budesonide | Netherlands | Authorised | 2022 |
| Budenofalk 9 mg maagsapresistent granulaatMaagsapresistent granulaat | Budesonide | Netherlands | Authorised | 2011 |
| Budosan 2 mg rektalna pjenaRektalna pjena | Budesonide | Croatia | Marketed | 2021 |
| Budosan 3 mg želučanootporne kapsuleželučanootporna kapsula, tvrda | Budesonide | Croatia | Marketed | 2021 |
| Budosan 4 mg čepićičepić | Budesonide | Croatia | Authorised | 2023 |
| CLETROVAGranulato a rilascio prolungato | Mesalazine | Italy | Authorised | |
| CLETROVAPROCTSupposta | Mesalazine | Italy | Authorised | |
| IMMUFALK 100 MG COMPRIMIDOS RECUBIERTOS CON PELICULA100 mg · Comprimido recubierto con película | Azathioprine | Spain | Marketed | 2017 |
| IMMUFALK 75 MG COMPRIMIDOS RECUBIERTOS CON PELICULA75 mg · Comprimido recubierto con película | Azathioprine | Spain | Marketed | 2017 |
| INTESTICORTCapsula rigida gastroresistente | Budesonide | Italy | Authorised | |
| INTESTICORTMONOGranulato gastroresistente | Budesonide | Italy | Authorised | |
| INTESTICORTPROCTSupposta | Budesonide | Italy | Authorised | |
| INTESTIFALK 2 mg/DOSIS ESPUMA RECTAL2 mg · Espuma rectal | Budesonide | Spain | Marketed | 2009 |
| INTESTIFALK 3 mg CAPSULAS GASTRORRESISTENTES3,00 mg · Cápsula dura gastrorresistente | Budesonide | Spain | Marketed | 2004 |
| INTESTIFALK 4 MG SUPOSITORIOS4 mg · Supositorio | Budesonide | Spain | Marketed | 2023 |
| INTESTIFALK UNO 9 mg GRANULADO GASTRORRESISTENTE9,0 mg · Granulado gastrorresistente | Budesonide | Spain | Marketed | 2012 |
| JORVEZACompressa orodispersibile | Budesonide | Italy | Authorised | |
| Jorveza | Budesonide | EU (EMA) | Authorised | 2018 |
| Jorveza 0,2 mg/ml suspensie voor oraal gebruikSuspensie voor oraal gebruik | Budesonide | Netherlands | Authorised | 2026 |
| JORVEZA 0,2 MG/ML SUSPENSION ORAL0,20 mg/ml · Suspensión oral | Budesonide | Spain | Authorised | 2026 |
| JORVEZA 0,5 MG COMPRIMIDOS BUCODISPERSABLES0,5 mg · Comprimido bucodispersable | Budesonide | Spain | Marketed | 2020 |
| Jorveza 0,5 mg, orodispergeerbare tabletOrodispergeerbare tablet | Budesonide | Netherlands | Authorised | 2018 |
| JORVEZA 1 MG COMPRIMIDO BUCODISPERSABLE1 mg · Comprimido bucodispersable | Budesonide | Spain | Marketed | 2018 |
| Jorveza 1mg orodispergeerbare tablettenOrodispergeerbare tablet | Budesonide | Netherlands | Authorised | 2018 |
| SALOFALK 1,5 g GRANULADO DE LIBERACION PROLONGADA1500,00 mg · Granulado de liberación modificada | Mesalazine | Spain | Marketed | 2008 |
Where it holds or makes medicines, with how many are current.
| Country | Medicines | Current | Past | Companies |
|---|---|---|---|---|
| Spain | 17 | 15 | 2 | CompaniesAll medicines |
| Croatia | 11 | 11 | 0 | CompaniesAll medicines |
| Netherlands | 11 | 11 | 0 | CompaniesAll medicines |
| Romania | 10 | 0 | 10 | CompaniesAll medicines |
| Italy | 6 | 6 | 0 | CompaniesAll medicines |
| European Union (EMA) | 1 | 1 | 0 | CompaniesAll medicines |
Also in the registers of Serbia, United Kingdom
The ATC groups most of its medicines belong to, largest first.
The active substances in most of its medicines.
How the registers spell it, normalised: legal forms, accents and capitals removed.
Compiled by Prognia from the public medicine and company registers below. Logos are not used.
Source: European Medicines Agency (EPAR data).
Licence: EMA reuse policy (source acknowledgement required)
Fuente de la información: AEMPS (CIMA).
Licence: AEMPS open data reuse with attribution
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA presentaciones, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Fuente de la información: Agencia Española de Medicamentos y Productos Sanitarios www.aemps.gob.es; CIMA medicamentos, acquired 11 October 2026 UTC; each source response/update date retained.
Licence: AEMPS explicit public open-data reuse for citizens and companies; source attribution and update date required
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 1 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:47.757811+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
Medicines and Healthcare products Regulatory Agency (MHRA), GOV.UK; Category 2 list; publication updated 25 August 2026; acquired 2026-10-15T08:18:48.423930+00:00; original workbook cells and factual authorization/holder projections adapted under Open Government Licence v3.0.
Licence: Open Government Licence v3.0; exact Crown copyright 2026 publication grant
HALMED, Baza lijekova, source export 08.10.2026., acquired 2026-10-08; factual structured adaptation; Otvorena dozvola RH, NN 67/2017.
Licence: Otvorena dozvola RH
Agenzia Italiana del Farmaco (AIFA); https://www.aifa.gov.it/documents/20142/3815901/Classe_A_per_principio_attivo_31-05-2026.csv; HTTP Last-Modified Mon, 28 Sep 2026 08:46:41 GMT; acquired 2026-10-13T17:21:06.055244+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
Agenzia Italiana del Farmaco (AIFA); https://drive.aifa.gov.it/farmaci/confezioni_fornitura.csv; HTTP Last-Modified Mon, 12 Oct 2026 23:02:44 GMT; acquired 2026-10-13T17:21:16.224007+00:00; native fields retained, source identifier and role projections are adaptations.
Licence: CC BY 4.0; AIFA published open-data catalog
College ter Beoordeling van Geneesmiddelen, Geneesmiddeleninformatiebank metadata, source update 07-10-2026; downloaded 08-10-2026; factual adaptation.
Licence: Conditional noncreative administrative factual metadata; no dataset-wide CC0 claim
Ministerul Sănătății, Catalogul public naţional al preţurilor, 18 iunie 2021, downloaded 2026-10-08 from data.gov.ro; CC BY 4.0; structured factual adaptation, code whitespace trimmed only where explicitly recorded.
Licence: Creative Commons Attribution 4.0 International (CC BY 4.0)
Report an error or request removalCorrections from the company itself are welcome.
ALIMS, Registar humanih lekova, source 08.10.2026 02:00, downloaded 2026-10-08, https://data.gov.rs/sr/datasets/lekovi-za-upotrebu-u-khumanoj-meditsini/; structured factual adaptation; Serbian Open Data Licence.
Licence: Serbian Open Data Licence (sodl)
Other companies in the same group.
Ranked by their number of medicines.